4/25
04:05 pm
rmd
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Medium
Report
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
4/25
11:44 am
rmd
XEALTH NAMED TO NEWSWEEK'S WORLD'S BEST DIGITAL HEALTH COMPANIES 2024 LIST [Yahoo! Finance]
Low
Report
XEALTH NAMED TO NEWSWEEK'S WORLD'S BEST DIGITAL HEALTH COMPANIES 2024 LIST [Yahoo! Finance]
4/22
10:56 am
rmd
ResMed (RMD) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
Low
Report
ResMed (RMD) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
4/19
04:56 pm
rmd
Sleeping Naked: Why Some Experts Warn Against It [Forbes]
Low
Report
Sleeping Naked: Why Some Experts Warn Against It [Forbes]
4/18
12:09 pm
rmd
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
4/17
06:58 pm
rmd
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank [Yahoo! Finance]
Low
Report
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank [Yahoo! Finance]
4/17
11:34 am
rmd
Wall Street Lunch: Lilly In Limelight [Seeking Alpha]
Low
Report
Wall Street Lunch: Lilly In Limelight [Seeking Alpha]
4/13
05:18 am
rmd
Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities [Seeking Alpha]
Low
Report
Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities [Seeking Alpha]
4/10
04:02 pm
rmd
Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree [Seeking Alpha]
Low
Report
Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree [Seeking Alpha]
4/10
08:43 am
rmd
CHILDREN'S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH [Yahoo! Finance]
Low
Report
CHILDREN'S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH [Yahoo! Finance]
4/8
05:14 am
rmd
Global Digital Therapeutics Market Research 2023: Market to Reach $46.8 Billion by 2033 from $4.9 Billion in 2022, Driven by Increasing Demand for Cost-Effective Solutions [Yahoo! Finance]
Low
Report
Global Digital Therapeutics Market Research 2023: Market to Reach $46.8 Billion by 2033 from $4.9 Billion in 2022, Driven by Increasing Demand for Cost-Effective Solutions [Yahoo! Finance]
4/8
04:39 am
rmd
Respiratory Care Devices Market To Reach USD 48.7 Billion By 2032, Report By DataHorizzon Research [Yahoo! Finance]
Low
Report
Respiratory Care Devices Market To Reach USD 48.7 Billion By 2032, Report By DataHorizzon Research [Yahoo! Finance]
4/7
10:27 am
rmd
ResMed: Not A Sleeper [Seeking Alpha]
Low
Report
ResMed: Not A Sleeper [Seeking Alpha]
4/4
04:05 pm
rmd
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
Low
Report
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
4/2
04:17 pm
rmd
Pulmonx appoints Mehul Joshi as CFO Apr. 02, 2024 4:10 PM ET By: Tiyashi Datta , SA News Editor [Seeking Alpha]
Low
Report
Pulmonx appoints Mehul Joshi as CFO Apr. 02, 2024 4:10 PM ET By: Tiyashi Datta , SA News Editor [Seeking Alpha]
4/1
04:56 pm
rmd
Sleep Apnea Devices Market Projected to Reach USD 11.68 Billion by 2029 with a CAGR of 7.33% [Yahoo! Finance]
Medium
Report
Sleep Apnea Devices Market Projected to Reach USD 11.68 Billion by 2029 with a CAGR of 7.33% [Yahoo! Finance]
4/1
02:42 pm
rmd
Here's Why Investors Should Buy ResMed (RMD) Stock Now [Yahoo! Finance]
Low
Report
Here's Why Investors Should Buy ResMed (RMD) Stock Now [Yahoo! Finance]
4/1
12:57 pm
rmd
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61% [Yahoo! Finance]
Low
Report
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61% [Yahoo! Finance]
4/1
08:09 am
rmd
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
Medium
Report
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
3/27
02:11 pm
rmd
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $215.00 price target on the stock.
Low
Report
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $215.00 price target on the stock.
3/20
09:45 pm
rmd
SINGAPORE'S "HUSTLE CULTURE" TAKES ITS TOLL: THE AIR STATION AND RESMED LAUNCH INITIATIVE TO ADDRESS WORK-INDUCED SLEEP ISSUES [Yahoo! Finance]
Low
Report
SINGAPORE'S "HUSTLE CULTURE" TAKES ITS TOLL: THE AIR STATION AND RESMED LAUNCH INITIATIVE TO ADDRESS WORK-INDUCED SLEEP ISSUES [Yahoo! Finance]
3/15
06:20 am
rmd
Sleep Apnea Devices Market, Industry Trends and Global Forecasts, 2035 [Yahoo! Finance]
Low
Report
Sleep Apnea Devices Market, Industry Trends and Global Forecasts, 2035 [Yahoo! Finance]
3/15
03:18 am
rmd
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis [Financial Post (Toronto, Ontario, Canada)]
Low
Report
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis [Financial Post (Toronto, Ontario, Canada)]
3/15
03:12 am
rmd
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis [Yahoo! Finance]
Low
Report
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis [Yahoo! Finance]
3/15
03:05 am
rmd
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
Low
Report
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis